Steven D Pearson

• Institute for Clinical and…
• Market Access

Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals

Read more

• Health Policy and Regulation
• Innovation
• Institute for Clinical and…
• Policy Analysis
• Pricing and Reimbursement
• US
• Drug Development/R&D

Value, Access, and Incentives for Innovation: Policy Perspectives on Alternative Models for Pharmaceutical Rebates

Read more

• Institute for Clinical and…
• Health Data and Statistics
• Real World Evidence (RWE)

Understanding the Context, Selecting the Standards: A Framework to Guide the Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions

Read more

• Institute for Clinical and…
• Health Data and Statistics
• Real World Evidence (RWE)

Real World Evidence for Coverage Decisions: Opportunities and Challenges

Read more

• Genetic
• HTA
• Institute for Clinical and…
• Cell and Gene Therapies
• Health Technology Assessment…

Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value

Read more